Clinical Trial Update: PTSD Symptom Reduction by Propranolol Given After Trauma Memory Activation [Phase 4]

View source ↗

Summary

Phase 4 trial investigating propranolol after trauma memory activation for PTSD; study terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Posttraumatic Stress Disorders | Phase 4 | Status: TERMINATED | Results posted: 2019-07-02